Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis

Inflammatory Bowel Diseases

Volumn 23, Issue 6, 2017, Pages 903-911

  Jacob, Vinita ^a   Crawford, Carl ^a   Cohen Mekelburg, Shirley ^a   Viladomiu, Monica ^a   Putzel, Gregory G ^a   Schneider, Yecheskel ^a   Chabouni, Fatiha ^a   O'Neil, Sarah ^a   Bosworth, Brian ^b   Woo, Viola ^a   Ajami, Nadim J ^c   Petrosino, Joseph F ^c   Gerardin, Ylaine ^d   Kassam, Zain ^d,e   Smith, Mark ^d,e   Iliev, Iliyan D ^a   Sonnenberg, Gregory F ^a   Artis, David ^a   Scherl, Ellen ^a   Longman, Randy S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Finch Therapeutics Group   (United States)

^e OpenBiome   (United States)

Author keywords

fecal microbiota transplantation; microbiome; ulcerative colitis

Indexed keywords

IMMUNOMODULATING AGENT; MERCAPTOPURINE; MESALAZINE; PREDNISONE; RNA 16S; VEDOLIZUMAB;

ADULT; AGED; ARTICLE; BLEEDING; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MALE; MICROBIAL DIVERSITY; MICROBIOME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM BIOPSY; REMISSION; SEQUENCE ANALYSIS; SEROLOGY; ULCERATIVE COLITIS; CYTOLOGY; FECES; GENETICS; INTESTINE FLORA; MICROBIOLOGY; MIDDLE AGED; NEW YORK; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PILOT STUDY; PROCEDURES; RECTUM; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; COLONOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED; NEW YORK; PILOT PROJECTS; PROSPECTIVE STUDIES; RECTUM; REMISSION INDUCTION; RNA, RIBOSOMAL, 16S; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85019701654     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000001132     Document Type: Article

References (22)

1. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368: 407-415.
2. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134: 577-594.
3. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015; 149: 110-118. e114.
4. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015; 149: 102-109. e106.
5. Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017; 389: 1218-1228.
6. Kump PK, Grochenig HP, Lackner S, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis. 2013; 19: 2155-2165.
7. Kelly LB, Koelsch E, Dubois N, et al. Prospective Laboratory Evaluation of Fecal Microbiota Transplantation Donors: Results From an International Public Stool Bank. New Orleans, LA: ID Week; 2015.
8. Diehl GE, Longman RS, Zhang JX, et al. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature. 2013; 494: 116-120.
9. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207-214.
10. Caporaso JG, Lauber CL, Walters WA, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. Isme J. 2012; 6: 1621-1624.
11. Buffington SA, Di Prisco GV, Auchtung TA, et al. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell. 2016; 165: 1762-1775.
12. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010; 26: 2460-2461.
13. Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013; 41: D590-D596.
14. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013; 10: 996-998.
15. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005; 71: 8228-8235.
16. Longman RS, Yang Y, Diehl GE, et al. Microbiota: host interactions in mucosal homeostasis and systemic autoimmunity. Cold Spring Harb Symp Quant Biol. 2013; 78: 193-201.
17. Viladomiu M, Kivolowitz C, Abdulhamid A, et al. IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote Th17-dependent inflammation. Sci Transl Med. 2017; 9(376).
18. Vaughn BP, Vatanen T, Allegretti JR, et al. Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease. Inflamm Bowel Dis. 2016; 22: 2182-2190.
19. Kverka M, Zakostelska Z, Klimesova K, et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2011; 163: 250-259.
20. Mazmanian SK, Liu CH, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005; 122: 107-118.
21. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013; 500: 232-236.
22. Tan TG, Sefik E, Geva-Zatorsky N, et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A. 2016; 113: E8141-E8150.